ISPE, a global not-for-profit association of 22,000 pharmaceutical science and manufacturing professionals, announced that it has released a new guidance document, titled ISPE Good Practice Guide: Process Gases. The guide aims to define current best practices within pharmaceutical manufacturing applications in regards to gases that come into direct contact with the biopharmaceutical and pharmaceutical process streams, such as nitrogen, oxygen, argon, and compressed air.

ISPE Good Practice Guide: Process Gases focuses on defining cost-effective engineering approaches and practices used to deliver a process gas system for a manufacturing facility in a timely manner that will meet its intended purpose. The guide provides information on how to avoid increasing facility installation and operation costs.

The primary focus of the Guide is to address the process of designing, constructing, commissioning and qualifying a process gas system regulated by international regulatory authorities, including the US FDA and the EMA. The Guide promotes a science- and risk-based approach to provide an effective basis for this process, and is intended to align with ICH Q9 and ASTM-E2500 principles.

ISPE, the International Society for Pharmaceutical Engineering, is a Society of 22,000 pharmaceutical professionals in 90 countries who use expert knowledge to create high-quality, cost-effective GMP solutions.